It was reported that a patient underwent a cardiac ablation procedure with three (3) thermocool® smart touch® sf bi-directional navigation catheter and there was loss of ecg signal with no intact signal available.When the physician started the ablation the ecg signals disappeared and impedance value started to change.There was no error on carto system.Fluoro tube wasn't too close to the location pad and it was in ap location.The cable was changed with new one but nothing changed.Finally, the catheter was changed to a new one.There was no patient consequences.On (b)(6) 2022, additional information was received indicating the physician did not have any intact ecg signal available to monitor patient heart rhythm.The signal loss was observed on all ecg (bs + ic) channels.The signal loss was observed on both carto® and recording system.During the signal loss issue the affected catheter was inside the patient¿s body.The impedance value was variable.The impedance cut-off value was not exceeded.The defibrillator was open and near the patient but it was not connected to the patient.The event was initially assessed as not mdr reportable until (b)(6) 2022 when information was received confirming there was no signal available to monitor patient's cardiac rhythm.
|
It was reported that a patient underwent a cardiac ablation procedure with three (3) thermocool® smart touch® sf bi-directional navigation catheter and there was loss of ecg signal with no intact signal available.When the physician started the ablation the ecg signals disappeared and impedance value started to change.There was no error on carto system.Fluoro tube wasn't too close to the location pad and it was in ap location.The cable was changed with new one but nothing changed.Finally, the catheter was changed to a new one.There was no patient consequences.Device evaluation details: the device was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.Visual inspection and temperature and impedance test of the returned device were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.A temperature and impedance test was performed and the device was found working correctly.No temperature or impedance issues were observed.An electrical test was performed, and no electrical issues were found.A manufacturing record evaluation was performed, and no internal actions related to the reported complaint condition were identified.The issue reported by the customer could not be replicated during the product investigation; other issues or circumstances may have occurred during the usage of the device that compromised its performance.The instructions for use contain the following recommendations: - when rf current is interrupted for either a temperature or an impedance rise (the set limit is exceeded), the catheter should be removed, and the tip cleaned of coagulum, if present.- ecg noise is typically generated as the result of the improper connection of the body surface ecg patch to the patient.This noise is the most significant during ablation.To resolve this situation, verify the proper connection.It is recommended to turn off the notch filter for this verification.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
On 18-may-2022, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|